GlassScriptPhysician profile
Bret A Cornn
NPI 1730105768
$4,463.24
in general payments reported to CMS, 2019-2025
35 companies · $638 in 2025
The $638 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $672 · 2022: $968 · 2023: $1,305 · 2024: $880 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $768.61 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $761.86 | 2021-2025 | |
| Glaxosmithkline, LLC. | $405.97 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $328.59 | 2021-2025 | Farxiga, Bevespi Aerosphere, Fasenra |
| Novartis Pharmaceuticals Corporation | $263.80 | 2021-2025 | |
| Pfizer INC. | $250.88 | 2021-2025 | |
| Novo Nordisk INC | $168.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.61 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Dexcom, INC. | $145.99 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $143.26 | 2021-2025 | Proclaim, Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $115.21 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $101.26 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.17 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.70 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $71.79 | 2021-2022 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Cornn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.